Amanote Research
Register
Sign In
P077 miR-338-3p Promotes the Resistance of Non-Small Cell Lung Cancers to EGFR-TKI by Targeting PTPN12
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.10.090
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
December 1, 2018
Authors
Q. Wu
F. Guo
Y. Li
W. Li
G. Ma
Y. Deng
W. Luo
Y. Zhao
F. Xu
Q. Zhou
Publisher
Elsevier BV
Related search
The miR‑625‑3p/AXL Axis Induces Non‑T790M Acquired Resistance to EGFR‑TKI via Activation of the TGF‑β/Smad Pathway and EMT in EGFR‑mutant Non‑small Cell Lung Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
Hsa_circ_0062389 Promotes the Progression of Non-Small Cell Lung Cancer by Sponging miR-103a-3p to Mediate CCNE1 Expression
Cancer genetics
Cancer Research
Genetics
Molecular Biology
Long Noncoding RNA HOXA-AS2 Promotes Non-Small Cell Lung Cancer Progression by Regulating miR-520a-3p
Bioscience Reports
Biochemistry
Cell Biology
Molecular Biology
Biophysics
miR‑144‑3p Regulates the Resistance of Lung Cancer to Cisplatin by Targeting Nrf2
Oncology Reports
Medicine
Cancer Research
Oncology
Circular RNA circFGFR1 Promotes Progression and Anti-Pd-1 Resistance by Sponging miR-381-3p in Non-Small Cell Lung Cancer Cells
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
miR‑338‑3p Inhibits A549 Lung Cancer Cell Proliferation and Invasion by Targeting AKT and Β‑catenin Signaling Pathways
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Third Generation EGFR TKI Landscape for Metastatic EGFR Mutant Non-Small Cell Lung Cancer (NSCLC)
Expert Review of Anticancer Therapy
Oncology
Pharmacology
miR‑671‑3p Is Downregulated in Non‑small Cell Lung Cancer and Inhibits Cancer Progression by Directly Targeting CCND2
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Epigenetic Silencing of miR-483-3p Promotes Acquired Gefitinib Resistance and EMT in EGFR-mutant NSCLC by Targeting Integrin Β3
Oncogene
Cancer Research
Genetics
Molecular Biology